Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/11/2008 | US20080306041 Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use |
12/11/2008 | US20080306037 Product for Use in the Prevention and Treatment of Cardiovascular Diseases, Cancer and Chronic Inflammatory Diseases |
12/11/2008 | US20080306025 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
12/11/2008 | US20080305999 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
12/11/2008 | US20080305993 Use of C1 Inhibitor for the Prevention of Ischemia-Reperfusion Injury |
12/11/2008 | US20080305991 Factor IX: remodeling and glycoconjugation of factor IX |
12/11/2008 | US20080305990 Method of Producing Fully Carbamylated Erythropoietin |
12/11/2008 | US20080305190 Salvia hispanica I (Chia) in the management and treatment of cardiovascular disease, diabetes and associated risk factors |
12/11/2008 | US20080305189 Treatment of aspirin resistance with radix salviae miltiorrhizae, its extract and composition |
12/11/2008 | US20080305158 Methods For the Preparation of Stable Pharmaceutical Solid Dosage Forms of Atorvastatin and Amlodipine |
12/11/2008 | US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof |
12/11/2008 | US20080305100 Activated Protein C Inhibits Undesirable Effects of Plasminogen Activator in the Brain |
12/11/2008 | US20080305095 Nutritional Drink |
12/11/2008 | US20080305090 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times |
12/11/2008 | US20080305088 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
12/11/2008 | CA2693552A1 Pyridone compound |
12/11/2008 | CA2689633A1 Use of ranolazine for elevated brain-type natriuretic peptide |
12/11/2008 | CA2689337A1 Crystalline form b of olmesartan medoxomil |
12/11/2008 | CA2688079A1 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis |
12/11/2008 | CA2687243A1 Piperidine/piperazine derivatives |
12/10/2008 | EP2000540A2 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
12/10/2008 | EP2000473A2 Trehalose compound and pharmaceutical comprising the compound |
12/10/2008 | EP2000465A1 Triazolone derivative |
12/10/2008 | EP2000176A1 Tetrahydroindole derivatives as NADPH Oxidase inhibitors |
12/10/2008 | EP2000152A2 Solid preparation having improved solubility |
12/10/2008 | EP2000142A1 Method for treating severe heart failure and medicament therefor |
12/10/2008 | EP2000136A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
12/10/2008 | EP1999123A1 Substituted chromanol derivatives and their use |
12/10/2008 | EP1999120A1 Benzothiazoles having histamine h3 receptor activity |
12/10/2008 | EP1999117A2 Renin inhibitors |
12/10/2008 | EP1999111A2 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists |
12/10/2008 | EP1999104A1 Salt of aliskiren with sulfuric acid |
12/10/2008 | EP1998778A1 Use of (s)-roscovitine for manufacturing a medicine |
12/10/2008 | EP1998761A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
12/10/2008 | EP1511730B1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
12/10/2008 | EP1475382B1 Compounds as semaphorin inhibitors |
12/10/2008 | EP1467735B1 Polymorphs of clopidogrel hydrogensulfate |
12/10/2008 | EP1404317B1 5-halo-tryptamine derivatives used as ligands of the 5-ht 6? and/or 5-ht 7? serotonin receptors |
12/10/2008 | EP1403284B1 HAb18G/CD147, ITS ANTAGONIST AND APPLICATION |
12/10/2008 | EP1396487B1 Phenylpyridine carbonyl piperazine derivative |
12/10/2008 | EP1391199B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
12/10/2008 | EP1326531A4 Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
12/10/2008 | EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
12/10/2008 | CN101321760A Pyrazolopyrimidines as protein kinase inhibitors |
12/10/2008 | CN101321745A Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
12/10/2008 | CN101321533A Combination therapy comprising substituted oxazolidinones for the prevention and treatment of cerebral circulatory disorders |
12/10/2008 | CN101319229A Recombined human bFGF and PDGF-B duplicate adenovirus carrier and uses thereof |
12/10/2008 | CN101318968A Benzoxazine-pyrazoles and opened loop compound |
12/10/2008 | CN101318934A 2'-oxatyl-4'fluorine biphenyl heterocycle ketone compound, preparation and application thereof |
12/10/2008 | CN101318932A 2'-oxatyl-5' fluorine biphenyl derivant, preparation and application thereof |
12/10/2008 | CN101317997A Preparation for effective component of turmeric |
12/10/2008 | CN101317982A Method for preparing capsule for cooling liver, removing wind, clearing heat and relieving spasm |
12/10/2008 | CN101317981A Method for preparing capsule for eliminating phlegm and relieving stuffiness |
12/10/2008 | CN101317962A Method for preparing capsule for clearing liver and reducing blood pressure |
12/10/2008 | CN101317952A Traditional Chinese medicine tea particle for treating coronary disease |
12/10/2008 | CN101317950A Method for preparing capsule for benefitting qi, nourishing blood, nourishing heart and pacifying the mind |
12/10/2008 | CN101317937A Method for preparing capsule for reliving Qi and reliving upset |
12/10/2008 | CN101317907A Compound testis powder capsule of panax ginseng |
12/10/2008 | CN101317906A Traditional Chinese medicine tea particle for hypertension reduction |
12/10/2008 | CN101317901A Method for preparing capsule for warming meridians and promoting circulation of qi |
12/10/2008 | CN101317869A Method for extracting flavone from capillary wormwood |
12/10/2008 | CN101317854A Soft capsule of heart blood of deer |
12/10/2008 | CN101317848A Eplerenone crystalline form |
12/10/2008 | CN101317842A Treating uses of imidazole-5-carboxylic acid derivant |
12/10/2008 | CN101317829A Nifedipine capsule and pill prescription and preparation thereof |
12/10/2008 | CN101317727A Pillow with health care function |
12/10/2008 | CN101317666A High-efficiency composite food cellulose and preparation method thereof |
12/10/2008 | CN101317655A Method for preparing natural food with additive ginseng |
12/10/2008 | CN101317639A Buck wheat piece and preparation method thereof |
12/10/2008 | CN101317617A Tea for treating cardiovascular disease and preparation method thereof |
12/10/2008 | CN101317615A Silver-thorn tea beverage and preparation method thereof |
12/10/2008 | CN100441594C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
12/10/2008 | CN100441589C Puerarin compound containing water soluble group and its preparation and use |
12/10/2008 | CN100441581C 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1,2-a]pyrimidin-5(1H)-one derivatives |
12/10/2008 | CN100441568C Aminocyclohexyl ether compounds and uses thereof |
12/10/2008 | CN100441563C Beta (3,4-dihydroxyphenyl)-alpha-hydroxyisopropyl propionate and its synthesis |
12/10/2008 | CN100441556C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
12/10/2008 | CN100441225C Amino-acid modified chitin nucleophic NO donor and its synthesis method |
12/10/2008 | CN100441220C Composition containing dipeptide of histidine and alanine for reducing uric acid |
12/10/2008 | CN100441217C A medicine for treating angina pectoris |
12/10/2008 | CN100441212C Chinese medicine for treating cardiac failure |
12/10/2008 | CN100441203C Method for preparing astragalus root saponin |
12/10/2008 | CN100441195C Medicinal composition containing safflower total flavone and its preparation process and usage |
12/10/2008 | CN100441194C Erigeron breviscapus extraction dry suspensoid agent |
12/10/2008 | CN100441186C Medical use of artificial lywrine |
12/09/2008 | US7462643 Essential fatty acids in the prevention of cardiovascular events |
12/09/2008 | US7462635 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia |
12/09/2008 | US7462630 Diarylalkene derivatives and novel diarylalkane derivatives |
12/09/2008 | US7462621 9-[3-(2-Fluorophenyl)-propyl]-7,7-dimethyl-2-(pyridin-4-yl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; neurodegenerative disease caused by abnormal activity of GSK3 beta (glycogen synthase kinase beta 3) or GSK3 beta and cdk5/p253 |
12/09/2008 | US7462620 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
12/09/2008 | US7462616 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
12/09/2008 | US7462593 Compositions and methods for promoting angiogenesis |
12/09/2008 | US7462592 Compositions and methods for polynucleotide delivery |
12/09/2008 | US7462370 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals |
12/09/2008 | US7462353 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis |
12/09/2008 | CA2453946C Process for the preparation of 3-spiro[cyclohexam-1,3'-[3h]indolin-2'-one] derivatives |
12/09/2008 | CA2425368C New sulphoxybenzamides |
12/09/2008 | CA2415447C Novel .gamma. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
12/09/2008 | CA2388142C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
12/09/2008 | CA2385871C Ltb4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition |